Treatment of Dilantin gingival hyperplasia with Proxigel.
D000328:Adult; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D005782:Gels / Q000627:therapeutic use; D005885:Gingival Hyperplasia / Q000139:chemically induced / Q000188:drug therapy* / Q000517:prevention & control; D005891:Gingivitis / Q000188:drug therapy; D006801:Humans; D008607:Intellectual Disability / Q000188:drug therapy; D008297:Male; D009910:Oral Hygiene; D010545:Peroxides / Q000627:therapeutic use*; D010672:Phenytoin / Q000009:adverse effects*; D010919:Placebos; D014508:Urea / Q000627:therapeutic use*
D005782:Gels; D010545:Peroxides; D010919:Placebos; D010672:Phenytoin; D014508:Urea